Next, lncMEG3 and p53 expression in glioma cells with/without MTE was determined by qRT‐PCR, with the outcomes highlighted that MTE treatment increased lncMEG3 and p53 expression in U87 and U251 cells (Figure 2C). The gene discussed is TP53; the disease is glioma.